There may be efficient means of extracting the maximum knowledge or actionable information from these trials. This talk is to "fire" up a discussion so we all as pharmaceutical scientists can think collectively.
Present different types of interferences to the clinical trials owing to COVID-19
Define the type of influences COVID-19 might have had on the proceeding of clinical trials.
Discuss potential solutions to still derive value from the trials.